All Menu
Search
KR
EN
CN
RU
MN
Цаг авах
Үзлэгийн цагийн хуваарь
Үзлэгийн цаг авах
Эмчилгээний тасгууд
Нарийн мэргэжлийн төв & тасаг хайх
Эмнэлгээр үйлчлүүлэх
Анхлан үйлчлүүлэгч
Амбулатори·яаралтай тусламж·эмнэлэгт хэвтэх
Давхруудын танилцуулга
Үйлчилгээний газрууд
Холбоо барих
Байршил
Түгээмэл асуулт хариултууд (FAQ)
Төрсний дараах сувилалын төв
Эрүүл мэндийн мэдээллүүд
Эрүүл мэндийн зөвлөгөө
Ча эмнэлгийн сошиал медиа
Эсэн мэнд амаржихын үндэс
Эрүүл мэндийн нэгдсэн үзлэг
Эрүүл мэндийн шинжилгээний төв
Хөтөлбөр
Бидний тухай
Эмнэлгийн танилцуулга
Хэтийн зорилго & Алсын хараа
Орчин үеийн эмнэлгийн тоног төхөөрөмж
Глобал Ча эмнэлэг
Холбоо барих
Байршил
We always promise
the best care
Prof. Kang, Sung Soo
Үзлэгийн захиалга
Мэргэжлийн салбар
Breast cancer
Үдээс өмнө
даваа, лхагва, баасан, бямба
Үдээс хойш
даваа, лхагва
Боловсролын байдал
Sungkyunkwan University
Catholic kwandong University
Dankook University
CHA University
Ажлын туршлага
Director of General Surgery, Cheil General Hospital
Director of Medical Department and Medical Planning, Cheil General Hospital
Director of General Surgery, CHA Ilsan Medical Center, CHA University
Breast Center, CHA Ilsan Medical Center, CHA University
Шагнал урамшуулал
Vice president, Korean Breast Cancer Society
Head, Directing board, Breast disease department, Korean Surgical Society
Research Fellow in Surgery, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA, U.S.A
Co-author, 4th edition, The breast, Korean Surgical Society
Судалгааны ажил
Five-year changes in ovarian function restoration in premenopausal patients with breast cancer taking tamoxifen after chemotherapy: An ASTRRA study report. European Journal of Cancer, Volume 151, July 2021, Pages 190-200
Clinical Outcomes Following Letrozole Treatment according to Estrogen Receptor Expression in Postmenopausal Women: LETTER Study (KBCSG-006). J Breast Cancer. 2021 Apr;24(2):164-174
Factors associated with disease upgrading in patients with papillary breast lesion. in coe-needle biopsy. Gland Surg. 2020;9(4):919-924.
A nationwide, multicenter retrospective study on the effectiveness and safety. of eribulin in Korean breast cancer patients (REMARK). The breast. 2020 Dec. 54:121-126.
Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial. J Clin Oncol, 2020 Feb 10;38(5):434-443.
Assessment of Quality of Life and Safety in Postmenopausal Breast Cancer Patients Receiving Letrozole as an Early Adjuvant Treatment. J Breast Cancer, 2018 June (공저)
The Usefulness of Intraoperative Circumferential Frozen-Section Analysis of Lumpectomy Margins in Breast-Conserving Surgery. J Breast Cancer, 2017 June (공저)
Primary osteosarcoma of the breast: a case report. Ann Surg Treat Res. 2017 July (교신저자)
Short-term outcomes of immediate breast reconstruction using an implant or tissue expander after mastectomy in breast cancer patients. Breast Cancer, 2016 Mar. (공저)
The Basic Facts of Korean Breast Cancer in 2013: Results of a Nationwide Survey and Breast Cancer Registry Database. J Breast Cancer, 2016 Mar., (공저)
The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled. BMC Cancer, 2016 May (공저)
The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database. J Breast Cancer, 2016 June (공저)
The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study. Breast Cancer Res Treat, 2015 May, (공저)
유방학(The Breast), 제 1 - 4판. (공저)
View more
예약
·
상담
Үзлэгийн цаг авах
Үзлэгийн цагийн хуваарь